The influence of precursor depletion and dose regimens on resistance to erythropoiesis-stimulating agents: insights from simulations with instantaneous dose-adaptation algorithm
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The influence of precursor depletion and dose regimens on resistance to erythropoiesis-stimulating agents: insights from simulations with instantaneous dose-adaptation algorithm
Authors
Keywords
-
Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.xphs.2023.10.037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
- (2022) David A. Goodkin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fate determination role of erythropoietin and romiplostim in the lineage commitment of hematopoietic progenitors
- (2022) Xiaoqing Fan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia
- (2022) Huixi Zou et al. PHARMACEUTICAL RESEARCH
- A Full Target-Mediated Drug Disposition (TMDD) Model to Explain the Changes in Recombinant Human Erythropoietin (rhEpo) Pharmacokinetics in Patients with Different Bone Marrow Integrity Following Hematopoietic Transplantation
- (2022) Nan Wu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chronic kidney disease
- (2021) Kamyar Kalantar-Zadeh et al. LANCET
- Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
- (2020) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients
- (2019) D. A. El Sewefy et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
- (2019) Ingrasciotta Ylenia et al. BMC Nephrology
- Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018
- (2018) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure)
- (2018) Peter van der Meer et al. Circulation-Heart Failure
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
- (2018) Mabel Aoun et al. PLoS One
- CKD prevention: Perspectives in Hong Kong
- (2018) Sydney CW Tang NEPHROLOGY
- Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients
- (2016) Jiacong Luo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure
- (2016) Yossi Chait et al. Hemodialysis International
- Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study
- (2016) Motoko Tanaka et al. PLoS One
- Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease
- (2015) Natalie A. Bello et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
- (2015) Myoung Nam Bae et al. PLoS One
- Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E
- (2014) J. Li et al. BLOOD
- Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
- (2013) Sameer Doshi et al. CLINICAL PHARMACOKINETICS
- Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
- (2013) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
- (2013) Marit M Suttorp et al. BMC Nephrology
- Hepcidin and iron homeostasis
- (2012) Tomas Ganz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis
- (2012) Juan José Pérez-Ruixo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor
- (2012) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Erythropoietin-Induced Erythroid Precursor Pool Depletion Causes Erythropoietin Hyporesponsiveness
- (2012) Xiaoyu Yan et al. PHARMACEUTICAL RESEARCH
- Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis-Stimulating Agents Requirement in Patients on Hemodialysis
- (2012) Yasuyuki Sato et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Time-dependent clearance and hematological pharmacodynamics upon erythropoietin multiple dosing in rats
- (2010) Sihem Ait-Oudhia et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
- (2010) Zoltán Kiss et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyporesponsiveness to Erythropoietin: Causes and Management
- (2009) James Elliott et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management
- (2009) Mehmet Kanbay et al. BLOOD PURIFICATION
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role
- (2008) Balaji Agoram et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started